Biologic and Biosimilar Therapies: Presentations

Thursday, 29 May 2014
Edmonton, Alberta

Moderator
Dianne Mosher, University of Calgary

09:00 – 09:15

Welcome and Opening Remarks

• Michele Evans, Executive Director, Pharmaceutical Funding and Guidance, Government of Alberta
  http://vimeo.com/album/3477664/video/97379108

09:15 – 09:30

Biologic and Biosimilar Therapies - The Changing Landscape of the Management of Rheumatoid Arthritis

• Biologic Therapies - The Changing Landscape of the Management of Rheumatoid Arthritis
  Dianne Mosher, Chief, Division of Rheumatology, Department of Medicine, University of Calgary
  Download Presentation 
  http://vimeo.com/album/3477664/video/97492592 

09:30 – 10:30

Biologic Therapies in Rheumatoid Arthritis Project

• Alberta Biologics Pharmacosurveillance Program
  Walter Maksymowych, Professor, University of Alberta, and
  Liam Martin, Professor, University of Calgary
  Download Presentation 
  http://vimeo.com/album/3477664/video/97648252 

10:45 – 12:30

Implications of Biologic Therapies for Rheumatoid Arthritis from multiple perspectives

• Patient Perspective
  Cheryl Koehn, Founder and President, Arthritis Consumer Experts (ACE)
  Download Presentation 
  http://vimeo.com/album/3477664/video/97594871 
• Public Payer Perspective
  Micheal Guirguis, Drug Stewardship Pharmacist, Alberta Health Services (AHS)
  Download Presentation 
  http://vimeo.com/album/3477664/video/97597295 
• Private Payer Perspective
  Suzanne Lepage, Private Health Plan Strategist
  Download Presentation 
  http://vimeo.com/album/3477664/video/97598794 
• Industry Perspective
  Cate McCready, VP External Affairs, BIOTECanada
  http://vimeo.com/album/3477664/video/97599947 

13:30 – 14:00

Health Canada's Policies on Biologic and Biosimilar Therapies

• Agnes Klein, Director, Centre for Evaluation of Radiopharmaceuticals and Biotherapeutics at Health Canada, Health Canada
  Download Presentation 
  http://vimeo.com/album/3477664/video/97604784 
  

  Note: Slide 16 of the above presentation contains an error in the indications for Omnitrope. The correct indications can be found in the Product Monograph at the following link: Government of Canada - Omnitrope Product Information

14:00 – 14:30

Biologics and Subsequent Entry Biologics: Health Technology Assessment Perspectives from CADTH and Common Drug Review, CDR

• Chander Sehgal, Director, Common Drug Review (CDR) and Optimal Use, Canadian Agency for Drugs and Technologies in Health (CADTH)
  Download Presentation 
  http://vimeo.com/album/3477664/video/97611990 

14:45 - 15:45

Panel Discussion

How does Alberta ensure its leading role for best patient outcomes for Rheumatoid Arthritis?

Moderator
Deborah Marshall, Associate Professor, University of Calgary and Arthur J.E. Child Chair in Rheumatology

Panelists
Walter Maksymowych, Liam Martin, Cheryl Koehn, Micheal Guirguis, Suzanne Lepage, Cate McCready, Chander Sehgal
http://vimeo.com/album/3477664/video/97629743 

View all videos in album: http://vimeo.com/album/3477664